Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia
European Journal of Internal Medicine , 08/28/09
Metan G et al. – Although severe underlying diseases play an important role in the clinical outcome of patients with Acb complex bacteraemia, carbapenem resistance and inappropriate therapy are of great concern. Special attention should be paid to infection control practices in the hospitals where MDR Acinetobacter infections are endemic, and well–controlled prospective clinical trials are needed to determine the optimal antimicrobial therapy in critically ill patients suspected of having MDR Acinetobacter bacteraemia.
Related Articles
In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore
The Journal of Antibiotics, 11/06/09
Relevance Score: 44%
Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland
BMJ - Archives of Diseases in Childhood, 10/29/09
Relevance Score: 44%
Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive bundle approach
American Journal of Infection Control, 11/10/09
Relevance Score: 42%
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii
Journal of Clinical Microbiology, 11/02/09
Relevance Score: 42%
Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case—control study
The Lancet, 10/20/09
Relevance Score: 42%
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Characterization of Baseline Methicillin-Resistant Staphylococcus aureus Isolates Recovered from Phase IV Clinical Trial for Linezolid
Journal of Clinical Microbiology, 12/03/09
Two antimalaria drugs are tolerated regimens in regions with resistance
Formulary , 12/02/09
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


